There are no longevity drugs today, but there will be soon - Dr. James Peyer, Cambrian Founder
Dr. James Peyer is founder and CEO of Cambrian Bio. James has spent two decades working to bring the first longevity drug to market. In this time, he’s brought over $500M into the field as a whole, and now has multiple drugs in clinical trials that could plausibly prove to be… the first true longevity drugs, or gerotherapeutics.In today’s episode, we dive into the history of the geroscience field. We discuss what makes geroscience’s approach to drug development so unique, how to unlock the flywheel of innovation that will get us longevity escape velocity, and Amplifier Therapeutics' “zone 2 in a pill”... which might prove to be the first ever true, longevity drug.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Free Radicals
The $101M XPRIZE to restore function by 10 - 20 years - Jamie Justice
How DARPA prepares for AI-designed bioweapons & is accelerating progress towards longevity biotech - Dr. Mike Koeris, DARPA Director
Replacement & Biostasis: radical approaches for solving aging - Kris Borer, Author & Investor
Selecting the Superman? Embyro selection with Jonathan Anomaly
Get summaries like this every morning.
Free AI-powered recaps of Free Radicals and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.